Your fact-checks will appear here
The use of insulin in treating type 2 diabetes, including its benefits and risks.
have signal of modest benefit for fasting glucose, insulin sensitivity and some lipid measures in people with , but trial results are inconsistent and effects on HbA1c are generally small and not unif...
Meaningful A1C reduction in type 2 diabetes is achieved by combining proven medications with sustained lifestyle changes: first‑line metformin plus weight‑loss–promoting agents (GLP‑1 receptor agonist...
Clinically proven alternatives to conventional metformin/sulfonylurea/insulin regimens for type 2 diabetes fall into three broad categories: newer approved or late‑stage pharmacotherapies that change ...